Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WelbyTSE:4438 +2.68%36 EV-to-EBIT is -4.48 as of Sep. 05, 2026. GuruFocus rates TSE:4438 with a GF Score™ of 36/100 and a GF Value™ of 円455.37 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Welby ranks worse than 209643.4% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Welby's Enterprise Value is 円2,379.2 Mil.
Welby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was 円-531.5 Mil. Therefore, Welby's EV-to-EBIT for today is -4.48.
The historical rank and industry rank for Welby's EV-to-EBIT or its related term are showing as below:
TSE:4438'
s EV-to-EBIT Range Over the Past 10 Years
Min: -3551.85 Med: -16.69 Max: 2283.72
Current: -4.47
During the past 10 years, the highest EV-to-EBIT of Welby was 2283.72. The lowest was -3551.85. And the median was -16.69.
TSE:4438's EV-to-EBIT is ranked worse than 100% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.52
vs TSE:4438: -4.47
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Welby's Enterprise Value for the quarter that ended in Jun. 2026 was 円2,151.5 Mil.
Welby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-531.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welby EV-to-EBIT Related Terms
Welby EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Welby's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4438 vs VEEV, BTSG, TEM: EV-to-EBIT Comparison
For the Health Information Services subindustry, Welby's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welby EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welby's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Welby's EV-to-EBIT falls into.
Welby's current Enterprise Value is 円2,379.2 Mil.
Welby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-531.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welby (TSE:4438) has a EV-to-EBIT of -4.48 as of Sep. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Welby and its competitors. According to the industry distribution chart, Welby ranks #999999 out of 477 companies in the Healthcare Providers & Services industry.
Is Welby's EV-to-EBIT too high?
Welby's current EV-to-EBIT is -4.48. Based on the distribution chart, Welby ranks #999999 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Welby has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Welby's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Welby ranks #999999 out of 477 companies for EV-to-EBIT. This places Welby in the lower half of its industry. The industry median EV-to-EBIT is 15.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.52, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Welby and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welby's current EV-to-EBIT is -4.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welby stock overvalued right now?
Based on GuruFocus' analysis, Welby (TSE:4438) is currently considered Possible Value Trap. The stock's GF Value™ is 円455.37, compared to a current price of 円268.00 — trading 41.1% below its estimated fair value. The current EV-to-EBIT is -4.48. Welby's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Welby (TSE:4438), the current EV-to-EBIT is -4.48 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welby (TSE:4438) Overvalued in 2026?
Based on GuruFocus' analysis, Welby stock appears to be undervalued.
The current stock price of 円268.00 is trading 41.1% below its estimated GF Value™ of 円455.37.
GuruFocus considers Welby to be Possible Value Trap.
Key valuation signals for TSE:4438:
EV-to-EBIT: -4.48
GF Value™: 円455.37 vs. price of 円268.00 (41.1% below fair value)
No single metric tells the full story. See the TSE:4438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.
36GF Score
Get the complete analysis for TSE:4438
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4438 has been successfully added to your 
